Sarepta Therapeutics, Inc.SRPTNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+81.7%
5Y CAGR+67.7%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+81.7%/yr
vs +42.2%/yr prior
5Y CAGR
+67.7%/yr
Recent acceleration
Acceleration
+39.4pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
13.2x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $839.61M | +163.1% |
| 2024 | $319.10M | +112.2% |
| 2023 | $150.34M | +7.4% |
| 2022 | $139.99M | +44.2% |
| 2021 | $97.05M | +53.1% |
| 2020 | $63.38M | +12.0% |
| 2019 | $56.59M | +65.5% |
| 2018 | $34.19M | +365.0% |
| 2017 | $7.35M | +5556.2% |
| 2016 | $130000.00 | - |